Home > > > > > Report Detail

Investigation Report on China Alendronate Sodium Market, 2010-2019

Publisher Name :
Date: 25-Jun-2015
No. of pages: 30

China has become the country with the largest number of people suffering from osteoporosis which is the most severe disease second to cardiovascular diseases. A nationwide largescale epidemiological survey has also shown that the incidence of osteoporosis in China is 12.4% and that this figure among elders is over 50%, among which nearly 33% suffer from fracture. It is estimated that the number of osteoporosis patients and patients with low bone mass will rise to 280 million by 2020. Hence osteoporosis drugs' promising future.

Alendronate sodium is one of the osteoporosis drugs with the longest history of application. And it is the first diphosphonate that got FDA's approval to be used for the treatment of postmenopausal osteoporosis and the first drug approved by FDA to treat osteoporosis in men.

By various mechanisms of action, alendronate sodium can enhance bone strength, alleviate and prevent osteoporosis, effectively reduce the risk of fracture in centrum, hip bone and other parts. It is also the only drug that can effectively reduce the risk in various parts of the body especially in hip.

Alendronate sodium develops fast after entering China, annual sales value rising from less than CNY 30 million in 2005 to CNY 121 million in 2014 and CAGR during this period reaching 18.14%. Merck Sharp & Dohme (Italy), CSPC Ouyi Pharmaceutical Co., Ltd, Beijing Wansheng Pharmaceutical Co., Ltd, Haini Pharmaceutical Co., Ltd and Chengdu Tiantaishan Pharmaceutical Co., Ltd occupy the majority of market share, among which Merck Sharp & Dohme (Italy) has the largest market share of nearly 90% for sales value in 2014.

The ageing population in China keeps growing, people aged 60 and above amounting to 212.42 million and occupying 15.5% of the total population while people aged 65 and above amounting to 137.55 million and occupying 10.1% of the total population by the end of 2014. With the ageing population, the incidence and number of cases of osteoporosis will continue to grow. Therefore the market size of alendronate sodium is expected to keep expanding in the next few years in China.

Readers can get at least the following information from this report:


  • market size of alendronate sodium in China

  • competitive landscape of alendronate sodium in Chinese market

  • price of alendronate sodium made by different enterprises in China

  • market outlook of alendronate sodium in China


The author suggests the following groups of people purchase this report:


  • manufacturers of osteoporosis drugs

  • investors/ research institutions interested in Chinese medicine market

  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Investigation Report on China Alendronate Sodium Market, 2010-2019

Table of Contents

1 Related Concepts of Alendronate Sodium
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Alendronate Sodium in China
2.1 Patent and Approval Status of Alendronate Sodium in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Alendronate Sodium in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Alendronate Sodium in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Alendronate Sodium in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Rreference Price of Alendronate Sodium in Chinese Hospitals in 2014
6.1 Haini Pharmaceutical Co., Ltd
6.2 Beijing Wansheng Pharmaceutical Co., Ltd (Trade Name: Anlun)
6.3 CSPC Ouyi Pharmaceutical Co., Ltd (Trade Name: Gubon)
6.4 Merck Sharp & Dohme (Italy) (Trade Name: Fosamax)

7 Major Manufacturers of Alendronate Sodium in Chinese Market, 2010-2014
7.1 Haini Pharmaceutical Co., Ltd
7.2 CSPC Ouyi Pharmaceutical Co., Ltd
7.3 Beijing Wansheng Pharmaceutical Co., Ltd
7.4 Chengdu Tiantaishan Pharmaceutical Co., Ltd
7.5 Merck Sharp & Dohme

8 Market Outlook of Alendronate Sodium in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Charts

Chart Patent Status of Alendronate Sodium in China
Chart Approval Information of Alendronate Sodium in China
Chart Sales Status of Alendronate Sodium in China
Chart Sales Value of Alendronate Sodium in China, 2010-2014
Chart Sales Value of Alendronate Sodium in Some Regions in China, 2010-2014
Chart Sales Volume of Alendronate Sodium in China, 2010-2014
Chart Sales Volume of Alendronate Sodium in Some Regions in China, 2010-2014
Chart Market Share of TOP3 Manufacturers of Alendronate Sodium for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Alendronate Sodium Made by Merck Sharp & Dohme (Italy) in China, 2010-2014
Chart Sales Value and Market Share of Alendronate Sodium Made by CSPC Ouyi in China, 2010-2014
Chart Sales Value and Market Share of Alendronate Sodium Made by Beijing Wansheng in China, 2010-2014
Chart Price of Alendronate Sodium Made by Haini Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Alendronate Sodium Made by Beijing Wansheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Alendronate Sodium Made by CSPC Ouyi Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Alendronate Sodium Made by Merck Sharp & Dohme (Italy) in Some Chinese Cities in 2014

  • Global Osteoporosis Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89
    According to our LPI (LP Information) latest study, the global Osteoporosis Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Osteoporosis Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Osteoporosis Drugs market. Osteoporosis Drugs are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Alendronate Sodium Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 130
    Alendronate sodium is used to prevent and treat osteoporosis. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios......
  • Global Alendronate Sodium Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Alendronate sodium is used to prevent and treat osteoporosis. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios......
  • Osteoporosis Drugs Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 93
    This study focuses on China's Osteoporosis Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. ......
  • Osteoporosis Drugs Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 67
    This study focuses on China's Osteoporosis Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions ......
  • Osteoporosis Drugs Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 205
    China's demand for Osteoporosis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, in......
  • Global Osteoporosis Drugs Market Research Report 2023, Forecast to 2028
    Published: 17-Nov-2023        Price: US 2680 Onwards        Pages: 139
    Bisphosphonates are usually the first choice for osteoporosis treatment. These include: Alendronate (Fosamax), a weekly pill. Risedronate (Actonel), a weekly or monthly pill. Ibandronate (Boniva), a monthly pill or quarterly intravenous (IV) infusion. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, ......
  • Global Risedronate Sodium Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Risedronate Sodium market: According to our latest research, the global Risedronate Sodium market looks promising in the next 5 years. As of 2022, the global Risedronate Sodium market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Risedronate Sodiu......
  • Global Raloxifene Hydrochloride Professional Survey Report 2023, Forecast to 2028
    Published: 07-Nov-2023        Price: US 3280 Onwards        Pages: 107
    Raloxifene Hydrochloride is the hydrochloride salt form of raloxifene, a selective benzothiophene estrogen receptor modulator (SERM) with lipid lowering effects and activity against osteoporosis. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advanta......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs